1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Digital Cities' Innovation Accelerator Small Grant Program is sponsored by Bureau of Cyberspace and Digital Policy, U.S. Department of State. These small grants activate the private sector to deliver novel and innovative solutions to civic challenges.
Projects must address a sub-national public service or infrastructure need and incorporate trusted U.S. digital-based solutions, promoting the responsible adoption of digital tools and empowering municipalities to improve public service delivery.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Private sector organizations. CDP prioritizes applications that include both U.S. and local organizations from Latin America and the Caribbean. Projects deploying technology must be at technology readiness level (TRL) 7 or higher. Confirm the full requirements in the official notice before applying.
The current listing shows $100,000 - $700,000 (Total available funding approximately $1,250,000). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Digital Cities' Innovation Accelerator Small Grant Program is funded by Bureau of Cyberspace and Digital Policy, U.S. Department of State. Verify program details on the funder's official page before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program
The NOURISH Autoimmunity Digital Health Challenge runs three phases to August 2028: 10 winners at $20,000, then 5 at $30,000, then 3 at $100,000. It is a prize competition, not a grant — no indirect costs, no cost reimbursement, and a rule that quietly disqualifies the obvious applicant.
Read articleNOT-OD-26-112 released a draft NIH Biosafety Policy for Research Involving Biohazards on August 19, 2026. It would replace the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, extend IBC jurisdiction from engineered molecules to wild-type agents, toxins and prions, impose 24-hour incident reporting, and make the Biosafety Officer a federally defined role. Here is what actually changes and how to respond before the October 19, 2026 deadline.
Read articleThe U.S. Government Policy for Stopping High-Risk Life Sciences Research, released July 28, 2026 under EO 14292 and implemented at NIH through NOT-OD-26-101, replaces mitigation with prohibition. It bans dangerous gain-of-function research outright, gates potential DGOF behind government-wide review, and creates International Research of Concern — a research-security regime wearing biosafety clothing. Penalties run to five-year debarment and False Claims Act exposure.
Read article